Two Sigma Advisers »

Achilles Therapeutics shares owned by Two Sigma Advisers

Quarter-by-quarter ownership of Achilles Therapeutics (ACHL) shares owned by Two Sigma Advisers from 13F filings

Historical chart of Two Sigma Advisers investment in Achilles Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Achilles Therapeutics held by Two Sigma Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Achilles Therapeutics by Two Sigma Advisers

Quarter filed Position value Share count Share price at filing
2024-06-30 $19k 24k 0.82
2024-03-31 $22k 18k 1.25

More positions owned by Two Sigma Advisers

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
Visa Com Cl A (V)
Costco Wholesale Corporation (COST)
Uber Technologies (UBER)
Mastercard Incorporated Cl A (MA)
Pfizer (PFE)
Crowdstrike Hldgs Cl A (CRWD)
Micron Technology (MU)
Abbott Laboratories (ABT)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Two Sigma Advisers

Top funds holding Achilles Therapeutics

Syncona Portfolio
BML Capital Management
Fcpm Iii Services B.v.
Redmile Group
Vestal Point Capital
Ikarian Capital
Siren
Renaissance Technologies
Acadian Asset Management
Two Sigma Advisers
Geode Capital Management
Two Sigma Investments
Corsair Capital Management
Baader Bank
Susquehanna International

View all funds holding Achilles Therapeutics